Related Experiment Video
Updated: Aug 5, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Temporal Trends in Palliative Care Integration for High-Grade Glioma: A Seven-Year Retrospective Cohort Study
Eduardo Abrão Spínola Rezk1, Mariana Soares Pinheiro1, Pablo Afonso Melo1
1Department of Neurosciences and Mental Health, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil.
None:
PurposeHigh-grade gliomas (HGG) have a poor prognosis and high symptom burden, yet palliative care (PC) integration remains limited. We evaluated temporal changes in PC referral and assessment patterns at a Brazilian tertiary center and explored prognostic factors for survival.MethodsThis is a non-concurrent retrospective cohort of 117 adults with HGG who underwent surgery between 2017 and 2023. Primary outcomes included rates of PC referral and effective assessment, time to referral, and functional status (Karnofsky Performance Status, KPS) at referral. Secondary outcomes included overall survival (OS) and identification of prognostic factors using Cox regression analysis. Temporal trends were analyzed using the Cochran-Armitage test.ResultsPC referral increased from 21.1% (2017) to 73.7% (2023) (P < 0.001), and effective assessment increased from 21.1% to 47.4% (P = 0.048). Median Karnofsky Performance Status at referral improved over time (P = 0.011). In multivariate analysis, baseline clinical factors (older age and lower preoperative KPS) predicted earlier mortality; PC referral and effective assessment were not independently associated with survival after adjustment.ConclusionOver seven years, a significant increase in PC referrals and an improvement in functional status at the time of PC access were observed. Preoperative functional status was the main determinant of survival.
More Related Videos
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014